Influenza
High-Dose Influenza Vaccine Shows Promising Results in Reducing Cardiovascular Hospitalizations
Recent research has shed light on the effectiveness of high-dose inactivated influenza vaccine (HD-IIV) in preventing hospitalizations for cardiovascular diseases in older adults. A Danish study published in the Journal of the American Medical Association (JAMA) Cardiology has found that HD-IIV may offer a 5.7% relative vaccine effectiveness (rVE)